A presentation of hemiplegia and recurrent melena in Osler Weber Rendu syndrome

Ayana S Kumar (1) , Akshaya Suresh (2) , Rakhi Krishna (3) , Anoop Koshy (4) , Roshni P R (5)
(1) Department of Pharmacy Practice, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi - 682041, Kerala, India, India ,
(2) Department of Pharmacy Practice, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi - 682041, Kerala, India, India ,
(3) Department of Pharmacy Practice, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi - 682041, Kerala, India, India ,
(4) Department of Pharmacy Practice, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi - 682041, Kerala, India, India ,
(5) Department of Gastroenterology, Amrita Institute of Medical Sciences and Research Center, Amrita Vishwa Vidyapeetham, Kochi - 682041, Kerala, India, India

Abstract

Osler Weber Rendu syndrome, synonymously Hereditary hemorrhagic telangiectasia, is a rare systemic disease with multiple-organ involvement. This genetic disorder inherits in an autosomal dominant fashion, with the incidence found closer to 1 in every 5,000 people. The condition can be diagnosed at any age and has an equal chance of affecting both males and females. A 74-year-old male, having a history of left hemiplegia, was admitted with a recent history of recurrent melena. An upper enteroscopy revealed bleeding telangiectasia in the proximal jejunum managed with hemoclips. The possibility of Osler Weber Rendu syndrome was considered as he developed bleeding recurrently. According to Curacao Criteria, a minimum of two out of four symptoms should be present to ratify the disease, and the presence of three symptoms makes a definite diagnosis. Since there is no cure for the syndrome to date, therapy's mainstay entails meticulous supportive care (focused on managing the manifestations). The disease is a type of arteriovenous malformation associated with the mutation in either endoglin (ENG) or activin A receptor-like kinase-1 (ACVRL1) genes. He was given an intraarticular injection of methotrexate in the left wrist hand because of small joint polyarthritis. The patient was symptomatically and clinically better on discharge. Novel treatment strategy includes bevacizumab and thalidomide though their use has not been clinically approved.

Full text article

Generated from XML file

Authors

Ayana S Kumar
Akshaya Suresh
Rakhi Krishna
Anoop Koshy
Roshni P R
roshnipr@aims.amrita.edu (Primary Contact)
Ayana S Kumar, Akshaya Suresh, Rakhi Krishna, Anoop Koshy, & Roshni P R. (2020). A presentation of hemiplegia and recurrent melena in Osler Weber Rendu syndrome. International Journal of Research in Pharmaceutical Sciences, 11(4), 7536–7538. Retrieved from https://ijrps.com/home/article/view/2336

Article Details

Most read articles by the same author(s)

No Related Submission Found